PREVAIL THERAPEUTICS INC
CUSIP 74140Y101
Prevail Therapeutics Inc has 30 institutional holders in Filings Flow’s 13F database, together reporting 21.15M shares worth $271M as of Q3 2019.
Institutional Holders
30
Q3 2019
Reported Value
$271M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2
Ownership Trend
Institutional holders
Total reported value
Holders
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| MetLife Investment Management, LLC$19.6B AUM | 0.00% | $106,505 | 7.1K | Q1 2024 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.